NCT00008853View on ClinicalTrials.gov

Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines

PHASE1CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2005

Conditions

Bacterial InfectionsGroup B Streptococcus

Interventions

BIOLOGICAL

GBS III-TT-SSI

BIOLOGICAL

GBS III-TT-MPHL

Trial Locations (1)

10011

AIDS Ctr, New York

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH